1 Min Read
Feb 21 (Reuters) - Neurovive Pharmaceutical AB
* Q4 loss before tax was SEK 14.6 million (7.4) Source text for Eikon: Further comOpany coverage: (Stockholm Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.